Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing Facilities
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This contract aims to enhance the understanding of drug shortages, particularly focusing on products susceptible to health fraud, and to identify ways outsourcing facilities can help address these shortages. It seeks to support research and development efforts by these facilities to create products that alleviate persistent drug shortages, thereby increasing the availability of critical medications. The overarching goal is to stabilize the drug supply chain and reduce vulnerabilities that lead to fraud. Administered by the Food and Drug Administration under the Department of Health and Human Services, the contract is designed as a forecast opportunity announced on July 21, 2025. The initiative emphasizes collaboration with outsourcing facilities to strengthen the drug supply network by mitigating risks associated with shortages and ensuring a reliable supply of essential medications. Patrick Johnson serves as the point of contact for this contract.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The goals of this grant are to better understand the landscape of drug shortage products, including those vulnerable to health fraud, and identify opportunities for outsourcing facilities to meet drug shortage needs to strengthen the supply chain. Funding would also support outsourcing facilities’ research and development of products that mitigate persistent drug shortages to increase supply of critical medications and stabilize the drug supply chain to prevent health fraud.
